Skip to main content
Premium Trial:

Request an Annual Quote

New Next-gen Sequencing Facilities in New York

NEW YORK (GenomeWeb News) – Empire Genomics, the University at Buffalo, and Life Technologies have joined to develop CLIA-certified next-generation sequencing facilities in upstate New York, they announced today.

The facilities will be set up at the UB's New York State Center of Excellence in Bioinformatics and Life Sciences and at the Buffalo, NY, headquarters of Empire Genomics. Life Technologies is providing Ion Torrent sequencers to the facilities.

The technology along with the expertise of UB researchers and Empire Genomics "will help researchers develop new diagnostic tests that, in the future, could enable physicians to prescribe treatments tailored to each individual based on genetic make-up," the three partners said.

Financial and other details of the deal were not disclosed.

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.